Two Dose Level BOTOX Patients w/Urinary Incontinence
ID Number 07-0890Principal Investigator(s)
Department(s) or Division(s)
The purpose of this study is to investigate the safety and effectiveness of each of two dosages of BOTOX® (200 U or 300 U) compared to placebo injected into the bladder in patients with incontinence due to neurogenic overactive bladder who have not been adequately managed with anticholinergic therapy.
Recruiting Patients: No